Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Hysterectomy: later-stage trial registry

3 of 9 indexed Hysterectomy trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 3 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Hysterectomy: 9 US clinical trials tracked, 3 recruiting.

Hysterectomy is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Mallinckrodt, running 1 of these trials.

Enrollment posture brief

Registry condition hysterectomy

OPEN 3 | RECR 33% | LATE 5 | EARLY 0 | RANK #1916 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Hysterectomy (this)33%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Hysterectomy

Hysterectomy lists 3 open slots (33% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hysterectomy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hysterectomy is recruiting below its size-band peers.

    3 of 9 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Hysterectomy trials is spread across many organizations.

    Mallinckrodt accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Hysterectomy enrolment sits around 100 participants.

    Median target enrolment is 100 among the 9 trials that report a genuine target (sentinel values excluded). 4 of those (44.4%) plan for fewer than 100 participants.

  4. Hysterectomy research is mostly interventional.

    9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 33Phase 42

Phase Distribution

PhaseTrial count
Phase 3 3
Phase 4 2

Named interventions

Most-linked intervention names on Hysterectomy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

IV Placebo 100 mL solution Drug
1 trials
Bladder filled with saline solution Other
1 trials
Normal Saline Procedure
1 trials
50% dextrose Procedure
1 trials
saline solution Other
1 trials
Laparoscopic Hysterectomy Procedure
1 trials
Ultravision System Device
1 trials
IV Acetaminophen Drug
1 trials

US sites by state

Facility locations filed on Hysterectomy trials. A trial with sites in several states counts in each.

New York 2 trials
Michigan 2 trials
California 2 trials
Arizona 2 trials
Alabama 2 trials
South Carolina 1 trials
Rhode Island 1 trials
New Jersey 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hysterectomy page

9 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Hysterectomy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Mallinckrodt sponsors the most Hysterectomy trials on record, review their full trial history before evaluating a specific study. See Mallinckrodt's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hysterectomy condition card totals 9 registered trials; most-linked intervention IV Placebo 100 mL solution; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.